Best Financial Markets Analysis Article Bob Doll, chief equity strategy at the world's largest money management firm BlackRock, spoke to Bloomberg TV's Trish Regan and Adam Johnson on "Street Smart" today. Doll said that he thinks equity valuations will grow stronger and "at S&P 1550, stocks would still not be expensive...If Europe continues to heal and the Middle East doesn't blow up, 1550 is do-able."

Bob Doll's predictions for the stock market:

"This isn't a year about economic growth or earnings, it's all about the probability of the left tail risk. How afraid are people? When the stock market yields the same as a ten-year Treasury, people are invested in a very afraid manner. My view is that this year is when fear dissipates some, the crisis premium comes out, the risk premium comes out and that means interest rates move up, spreads narrow and equity valuations move up."

"Our target coming into the year was S&P 1350 plus because our prediction was a double-digit gain in stocks. If Europe stays in the background and behaves itself, we could see a whole lot of the plus and this could be a great year for equities."

"We're not changing our target. We could see 1550, and our target will still be accurate. It's all about Europe, if that left tail risk dissipates. At S&P 1550 stocks would still not be expensive...If Europe continues to heal and the Middle East doesn't blow up, 1550 is do-able."

On why market volume is so low:

"There's still a lot of cash on the sidelines waiting to come in....I'm being a bit extreme, but I think stocks are the place to be. At some point we'll get a pullback, we'll get a sloppy period as things will go sideways, you've seen the mini-corrections and they last about one day and half because there's some many people are waiting for a pullback."

On what equities to invest in:

"I still think having a cyclical orientation - meaning you want to own technology, some energy, but I'm not afraid to buy some healthcare either to get some defense in the portfolio. What you really want is companies with good free cash flow."

On bank stocks:

"We have more [bank] banks than we did six months ago, but still not a big weighting there. While they've done well, I'm still concerned about where the revenue growth is coming from, what's the regulatory environment means. [The stress tests] were certainly a positive step in the right direction, but stress tests are all about credit...For earnings to grow, it's not going to be about less bad news, but where's the revenue growth?"

On interest rates impact on stocks:

"For me, it's about the pace of increase rather than the level. If we go up 10 basis points per day, as we did early this week, I'm going to get scared fast, but if it's slow but steady as I'm expecting, not a problem at all. Stocks are still cheap relative to bonds."

"In a zero interest rate environment, at the short-end, 2 percent for a 10-year Treasury and very little inflation, 14 times growth for the S&P is cheap."

"We're up 30% since the low of October 1st - for six months, that seems pretty quick for me. I think some people are just praying for a pull-back so they can put some money in."

On QE3:

"I don't think we're going to get QE3 if the U.S. economy is growing anywhere close to 3% and unemployment is falling. That's hardly the condition for an emergency, and QE3 is for emergencies. We don't have one, so I think it's on the back burner... The Fed's been a little bit more forward about that and markets have hung in there. For the bears among you, we're appreciating at a slower rate. We're a little overbought. We'll get a correction, but a correction could just be time without much change in price."

bloomberg.com

Copyright © 2012 Bloomberg - All Rights Reserved Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.